Revolution Medicines, Inc.
RVMD
Rank in Stocks
#619
Revolution Medicines, Inc. is a precision oncology firm operating in the... Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic arsenal, Revolution Medicines is advancing RMC-6291, which selectively inhibits mutated forms of KRASG12C(ON) and NRASG12C(ON). Another promising compound, RMC-6236, specifically targets and inhibits a range of active RAS(ON) variants. Its research efforts also encompass other active RAS inhibitors aimed at KRASG13C(ON) and KRASG12D(ON) mutations. Revolution Medicines has established a collaborative partnership with Sanofi to research and develop SHP2 inhibitors, a collaboration that includes the development of RMC-4630. Established in 2014, Revolution Medicines, Inc. operates from its corporate headquarters situated in Redwood City, California.
Share Price
$182.91
Last synced: 2026-10-19
Market Cap
$39.20B
Change (1 day)
2.78%
Change (1 year)
238.66%
Country
US
Trade Revolution Medicines, Inc. (RVMD)
Category
Healthcare
Number of shares outstanding for Revolution Medicines, Inc. (RVMD)
Number of shares outstanding as of June 2026: 210.89M
According to Revolution Medicines, Inc. latest financial reports and stock price the company's current number of shares outstanding is 210.89M. At the end of December 2023 the company had 113.15M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Revolution Medicines, Inc. (RVMD) from 2017 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 210.89M | 25.73% |
| 2024 | 167.74M | 48.24% |
| 2023 | 113.15M | 40.34% |
| 2022 | 80.63M | 10.74% |
| 2021 | 72.81M | 9.32% |
| 2020 | 66.60M | 82.60% |
| 2019 | 36.47M | 0.00% |
| 2018 | 36.47M | 0.00% |
| 2017 | 36.47M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | 20.39% |
US
|
|
| 396.00M | 87.77% |
US
|
|
| 478.91M | 127.09% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -70.51% |
NL
|
